Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | MLH1 |
| Variant | E633Kfs*4 |
| Impact List | frameshift |
| Protein Effect | loss of function - predicted |
| Gene Variant Descriptions | MLH1 E633Kfs*4 indicates a shift in the reading frame starting at amino acid 633 and terminating four residues downstream causing a premature truncation of the 756 amino acid Mlh1 protein (UniProt.org). E633Kfs*4 results in loss of interaction with Pms2 and Exo1 in a yeast-two-hybrid assay, reduced Pms2 expression in an in vitro assay (PMID: 12810663), and due to loss of the C-terminal domain (PMID: 16338176), is predicted to lead to a loss of Mlh1 protein function. |
| Associated Drug Resistance | |
| Category Variants Paths |
MLH1 mutant MLH1 inact mut MLH1 E633Kfs*4 |
| Transcript | NM_000249.4 |
| gDNA | chr3:g.37048517delG |
| cDNA | c.1897delG |
| Protein | p.E633Kfs*4 |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_000249.4 | chr3:g.37048517delG | c.1897delG | p.E633Kfs*4 | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|